Houston we have an announcement!!!
..........and a mighty fine one at that ..... IND application filed to the US FDA and on target for clinical trials 4th quarter.
Toot..toot..toot..toot.
Ann: Novogen submits IND Application to the FDA for Cantrixil-NRT.AX, page-4
Add to My Watchlist
What is My Watchlist?